These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 2761587)
1. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. Hass WK; Easton JD; Adams HP; Pryse-Phillips W; Molony BA; Anderson S; Kamm B N Engl J Med; 1989 Aug; 321(8):501-7. PubMed ID: 2761587 [TBL] [Abstract][Full Text] [Related]
2. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114 [TBL] [Abstract][Full Text] [Related]
3. Antiplatelet therapy in the prevention of ischaemic stroke. Verry M; Panak E; Cazenave JP Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242 [TBL] [Abstract][Full Text] [Related]
4. A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study. Bergamasco B; Benna P; Carolei A; Rasura M; Rudelli G; Fieschi C Funct Neurol; 1997; 12(1):33-43. PubMed ID: 9127122 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study. Bellavance A Stroke; 1993 Oct; 24(10):1452-7. PubMed ID: 8378945 [TBL] [Abstract][Full Text] [Related]
6. Ticlopidine hydrochloride use and threatened stroke. Rothrock JF; Hart RG West J Med; 1994 Jan; 160(1):43-7. PubMed ID: 8128701 [TBL] [Abstract][Full Text] [Related]
7. Ticlopidine hydrochloride and prevention of stroke. Macko R West J Med; 1993 Aug; 159(2):182. PubMed ID: 8212686 [No Abstract] [Full Text] [Related]
8. A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic events. Haynes RB; Sandler RS; Larson EB; Pater JL; Yatsu FM Arch Intern Med; 1992 Jul; 152(7):1376-80. PubMed ID: 1627017 [TBL] [Abstract][Full Text] [Related]
9. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. Yusuf S; Zhao F; Mehta SR; Chrolavicius S; Tognoni G; Fox KK; N Engl J Med; 2001 Aug; 345(7):494-502. PubMed ID: 11519503 [TBL] [Abstract][Full Text] [Related]
10. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Kasner SE; Benesch CG; Sila CA; Jovin TG; Romano JG; N Engl J Med; 2005 Mar; 352(13):1305-16. PubMed ID: 15800226 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
12. Ticlopidine versus aspirin for the prevention of recurrent stroke. Analysis of patients with minor stroke from the Ticlopidine Aspirin Stroke Study. Harbison JW Stroke; 1992 Dec; 23(12):1723-7. PubMed ID: 1448821 [TBL] [Abstract][Full Text] [Related]
13. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. Ann Neurol; 1997 Dec; 42(6):857-65. PubMed ID: 9403477 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of and stroke-preventive strategies for atherothromboembolic brain infarction in the elderly. Adams HP; Gordon DL Clin Geriatr Med; 1991 Aug; 7(3):401-16. PubMed ID: 1868399 [TBL] [Abstract][Full Text] [Related]
15. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. UK-TIA Study Group. Uk-Tia Study Group Br Med J (Clin Res Ed); 1988 Jan; 296(6618):316-20. PubMed ID: 2894232 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators. Arch Intern Med; 1997 Jun; 157(11):1237-40. PubMed ID: 9183235 [TBL] [Abstract][Full Text] [Related]
17. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660 [TBL] [Abstract][Full Text] [Related]
18. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Berger PB; Bhatt DL; Fuster V; Steg PG; Fox KA; Shao M; Brennan DM; Hacke W; Montalescot G; Steinhubl SR; Topol EJ; Circulation; 2010 Jun; 121(23):2575-83. PubMed ID: 20516378 [TBL] [Abstract][Full Text] [Related]
19. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel. Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380 [TBL] [Abstract][Full Text] [Related]
20. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P; N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]